New diabetes clinical trial: Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls

Published on: January 22, 2025 at 11:00PM
Conditions: Central Diabetes Insipidus
Interventions: Drug: MDMA; Other: Placebo
Sponsors: University Hospital, Basel, Switzerland
Not yet recruiting
https://ift.tt/lo6QwD1